
President Trump announced potential tariffs on imported pharmaceuticals by month's end, followed by semiconductor levies. These actions, under Section 232, aim to bolster US production, citing national security concerns due to high import volumes. The pharmaceutical tariffs could significantly impact major drugmakers, while semiconductor tariffs may affect tech giants and consumer prices.
from Latest Business News Today: Stock Markets, Financial News, India Business & World Business News https://ift.tt/E3NiQ1A
Comments
Post a Comment